JP2013525801A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525801A5 JP2013525801A5 JP2013508294A JP2013508294A JP2013525801A5 JP 2013525801 A5 JP2013525801 A5 JP 2013525801A5 JP 2013508294 A JP2013508294 A JP 2013508294A JP 2013508294 A JP2013508294 A JP 2013508294A JP 2013525801 A5 JP2013525801 A5 JP 2013525801A5
- Authority
- JP
- Japan
- Prior art keywords
- daltons
- autism
- cellular
- signature
- metabolite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32951510P | 2010-04-29 | 2010-04-29 | |
| US61/329,515 | 2010-04-29 | ||
| PCT/US2011/034654 WO2011139914A1 (en) | 2010-04-29 | 2011-04-29 | Metabolic biomarkers of autism |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015189529A Division JP2015231392A (ja) | 2010-04-29 | 2015-09-28 | 自閉症の代謝バイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013525801A JP2013525801A (ja) | 2013-06-20 |
| JP2013525801A5 true JP2013525801A5 (enExample) | 2014-05-22 |
| JP6021187B2 JP6021187B2 (ja) | 2016-11-09 |
Family
ID=44533446
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013508294A Expired - Fee Related JP6021187B2 (ja) | 2010-04-29 | 2011-04-29 | 自閉症の代謝バイオマーカー |
| JP2015189529A Pending JP2015231392A (ja) | 2010-04-29 | 2015-09-28 | 自閉症の代謝バイオマーカー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015189529A Pending JP2015231392A (ja) | 2010-04-29 | 2015-09-28 | 自閉症の代謝バイオマーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9547013B2 (enExample) |
| EP (1) | EP2564194B1 (enExample) |
| JP (2) | JP6021187B2 (enExample) |
| AU (2) | AU2011248464B2 (enExample) |
| CA (1) | CA2797787C (enExample) |
| WO (1) | WO2011139914A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101322695B1 (ko) * | 2010-08-25 | 2013-10-25 | 주식회사 엘지화학 | 케이블형 이차전지 |
| LT3072524T (lt) | 2010-10-07 | 2018-03-26 | California Institute Of Technology | Probiotikai, skirti autizmo gydymui |
| EP2890808A4 (en) * | 2012-08-29 | 2016-09-28 | California Inst Of Techn | DIAGNOSIS AND TREATMENT OF AUTISTICAL DISEASES |
| MX2016000293A (es) * | 2013-07-09 | 2016-06-21 | Stemina Biomarker Discovery Inc | Biomarcadores del trastrono del espectro autista. |
| US20160209428A1 (en) * | 2013-08-21 | 2016-07-21 | The Regents Of The University Of California | Diagnostic and predictive metabolite patterns for disorders affecting the brain and nervous system |
| AU2015243857A1 (en) * | 2014-04-08 | 2016-10-20 | Metabolon, Inc. | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment |
| US9176113B1 (en) | 2014-04-11 | 2015-11-03 | Synapdx Corporation | Methods and systems for determining autism spectrum disorder risk |
| US20150294081A1 (en) | 2014-04-11 | 2015-10-15 | Synapdx Corporation | Methods and systems for determining autism spectrum disorder risk |
| EP3212207A4 (en) | 2014-10-30 | 2018-06-13 | California Institute of Technology | Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders |
| JP6800846B2 (ja) | 2014-10-30 | 2020-12-16 | カリフォルニア インスティチュート オブ テクノロジー | 神経発達症群における行動の改善のための細菌含有組成物、及び細菌を使用することを含む、神経発達症群における行動の改善のための方法 |
| EP3265820B1 (en) | 2015-03-06 | 2023-12-13 | Micromass UK Limited | Spectrometric analysis of microbes |
| CA2978042A1 (en) | 2015-03-06 | 2016-09-15 | Micromass Uk Limited | Tissue analysis by mass spectrometry or ion mobility spectrometry |
| CN112557491B (zh) * | 2015-03-06 | 2024-06-28 | 英国质谱公司 | 光谱分析 |
| GB2556436B (en) | 2015-03-06 | 2022-01-26 | Micromass Ltd | Cell population analysis |
| JP6421742B2 (ja) | 2015-11-27 | 2018-11-14 | 株式会社デンソー | 車両制御装置 |
| WO2017178833A1 (en) | 2016-04-14 | 2017-10-19 | Micromass Uk Limited | Spectrometric analysis of plants |
| CN109642904A (zh) | 2016-05-23 | 2019-04-16 | 加州理工学院 | 调节肠微生物群来治疗神经退行性病症 |
| CN107064340A (zh) * | 2017-03-13 | 2017-08-18 | 瀚盟测试科技（天津）有限公司 | 一种检测茶叶中gaba含量的方法 |
| WO2018213204A1 (en) | 2017-05-15 | 2018-11-22 | Axial Biotherapeutics, Inc. | Inhibitors of microbially induced amyloid |
| GB201802116D0 (en) | 2018-02-09 | 2018-03-28 | Univ Warwick | Methods for diagnosing an autistic spectrum disorder |
| CN109030665A (zh) * | 2018-10-08 | 2018-12-18 | 黑龙江大学 | 亲水性液相色谱串联质谱法测定红甜菜中甜菜碱含量的检测方法 |
| KR102550459B1 (ko) | 2018-11-06 | 2023-07-03 | 스탈리클라 에스에이 | 특발성 자폐 스펙트럼 장애 환자의 하위 집단, asd 표현형 1의 진단을 위한 대사 프로파일링 |
| EP4012414A1 (en) | 2020-12-11 | 2022-06-15 | Stalicla S.A. | Diagnosis of autism spectrum disorder phenotype 1 |
| CN113960200B (zh) * | 2021-10-19 | 2023-06-20 | 首都医科大学附属北京儿童医院 | 代谢标志物在诊断儿童adhd合并抽动障碍中的应用 |
| CN114705775B (zh) * | 2022-03-31 | 2023-09-12 | 广东省结核病控制中心 | 一种肺结核评价的血清代谢标志物及其应用 |
| CN115326953A (zh) * | 2022-08-02 | 2022-11-11 | 云谱康(大连)生物科技有限公司 | 一种代谢物组合及应用和检测试剂盒与使用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686311A (en) * | 1995-06-23 | 1997-11-11 | The Children's Mercy Hospital | Diagnosis of autism and treatment therefor |
| CA2273683A1 (en) * | 1998-06-15 | 1999-12-15 | Ortho-Clinical Diagnostics, Inc. | Diagnostic markers for human disorders |
| CA2511501A1 (en) | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
| GB0504096D0 (en) | 2005-02-28 | 2005-04-06 | Tipogen As | Method |
| WO2006121952A2 (en) * | 2005-05-05 | 2006-11-16 | The Regents Of The University Of California | Diagnostic biomarkers for neurodevelopmental disorders |
| EP2013619B1 (en) * | 2006-04-10 | 2017-10-11 | Wisconsin Alumni Research Foundation | Methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds & other chemicals |
| EP2052255A2 (en) * | 2006-08-18 | 2009-04-29 | Huntington Medical Research Institutes | Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases |
| EP2183589A4 (en) * | 2007-07-26 | 2011-03-16 | Phenomenome Discoveries Inc | METHODS FOR THE DIAGNOSIS, RISK ASSESSMENT AND MONITORING OF AUTISM SPECTRUM DISORDERS |
| US20100248235A1 (en) * | 2007-10-04 | 2010-09-30 | Scherer Stephen W | Biomarkers for autism spectrum disorders |
| EP2279417B1 (en) * | 2008-05-28 | 2016-07-20 | Georgia Tech Research Corporation | Metabolic biomarkers for ovarian cancer and methods of use thereof |
-
2011
- 2011-04-29 CA CA2797787A patent/CA2797787C/en active Active
- 2011-04-29 JP JP2013508294A patent/JP6021187B2/ja not_active Expired - Fee Related
- 2011-04-29 EP EP11721395.9A patent/EP2564194B1/en active Active
- 2011-04-29 US US13/098,249 patent/US9547013B2/en active Active
- 2011-04-29 WO PCT/US2011/034654 patent/WO2011139914A1/en not_active Ceased
- 2011-04-29 AU AU2011248464A patent/AU2011248464B2/en active Active
-
2015
- 2015-09-28 JP JP2015189529A patent/JP2015231392A/ja active Pending
-
2016
- 2016-07-15 AU AU2016204969A patent/AU2016204969B2/en active Active
- 2016-12-07 US US15/371,692 patent/US10330688B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013525801A5 (enExample) | ||
| CA2797787A1 (en) | Metabolic biomarkers of autism | |
| Wang et al. | Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression | |
| Uřinovská et al. | Liquid chromatography–tandem mass spectrometry method for determination of five antidepressants and four atypical antipsychotics and their main metabolites in human serum | |
| Puchades-Carrasco et al. | Metabolomics in pharmaceutical research and development | |
| EP3019624B1 (en) | Biomarkers of autism spectrum disorder | |
| Xu et al. | Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer’s disease | |
| Saheb Sharif-Askari et al. | Saliva metabolomic profile of COVID-19 patients associates with disease severity | |
| JP2019035767A (ja) | 乳癌検出用唾液バイオマーカー、及び、これを用いた乳癌患者を健常者から識別する方法 | |
| Enche Ady et al. | Metabolomic‐guided discovery of Alzheimer's disease biomarkers from body fluid | |
| Jie et al. | Life history recorded in the vagino-cervical microbiome along with multi-omes | |
| CN105738626B (zh) | 一种新的血清代谢物的组合及其作为肝癌诊断标志物的用途 | |
| WO2017082103A1 (ja) | うつ病診断用バイオマーカー及びその使用 | |
| Quintero et al. | Metabolomic biomarkers in mental disorders: bipolar disorder and schizophrenia | |
| Quanico et al. | Parafilm-assisted microdissection: a sampling method for mass spectrometry-based identification of differentially expressed prostate cancer protein biomarkers | |
| JP2018077253A5 (enExample) | ||
| CN116678974A (zh) | 一种阿尔茨海默症血浆代谢标志物的筛选方法、血浆代谢标志物及应用 | |
| Li et al. | Dysregulation of glutamine/glutamate metabolism in COVID‐19 patients: A metabolism study in African population and mini meta‐analysis | |
| Bonomo et al. | Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting | |
| CN112305121B (zh) | 代谢标志物在动脉粥样硬化性脑梗死中的应用 | |
| WO2015168426A1 (en) | Metabolic and genetic biomarkers for memory loss | |
| WO2018191866A1 (zh) | 2型糖尿病标志物及其用途 | |
| Zhao et al. | Saliva metabolomics: A non-invasive frontier for diagnosing and managing oral diseases | |
| JP7681882B2 (ja) | フレイルの判定方法 | |
| Lei et al. | Multiomics analysis unveils key biomarkers during dynamic progress of IAV infection in mice |